Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. (2020). SKIN The Journal of Cutaneous Medicine, 4(1), S5. https://skin.dermsquared.com/skin/article/view/809